Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmuCell Corp (NASDAQ:ICCC)

5.41
Delayed Data
As of 3:58pm ET
 +0.06 / +1.12%
Today’s Change
4.76
Today|||52-Week Range
8.24
-9.08%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues6.0M7.6M10.2M9.5M
 
 
 
 
 
Cost of Goods Sold2.5M2.7M3.5M3.3M
 
 
 
 
 
Depreciation And Amortization417.2K446.0K525.9K802.4K
 
 
 
 
 
 
Operating ExpensesGross Income3.1M4.4M6.3M5.4M
 
 
 
 
 
General Expenses3.1M4.7M4.1M4.5M
 
 
 
 
 
Research And Development1.2M2.2M1.2M1.2M
 
 
 
 
 
Total Operating Expenses6.0M7.8M8.1M8.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-19.6K-206.4K2.1M890.2K
 
 
 
 
 
Interest Expense On Debt69.6K60.7K83.6K161.7K
 
 
 
 
 
Other Expenses281.9K-3.9K5.6K-24.8K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income205.3K-255.5K2.1M758.3K
 
 
 
 
 
Income Taxes-87.9K-88.3K-850.3K-249.9K
 
 
 
 
 
Net Income117.4K-167.2K1.2M508.4K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS3.0M3.0M3.0M4.2M
 
 
 
 
 
Shares To Calculate EPS Diluted3.1M3.0M3.2M4.3M
 
 
 
 
 
 
Earnings Per ShareEPS$0.04-$0.06$0.38$0.12
 
 
 
 
 
EPS Diluted$0.04-$0.06$0.38$0.12